KWALITY PHARMACEUTICALS
Back to Cashflow Statement
|
KWALITY PHARMACEUTICALS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-14 Cr | ₹-17 Cr | ₹0.99 Cr | ₹5.66 Cr | ₹0.77 Cr |
What is the latest Cash Flow from Financing Activities ratio of KWALITY PHARMACEUTICALS ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-14 Cr |
| Mar2024 | ₹-17 Cr |
| Mar2023 | ₹0.99 Cr |
| Mar2022 | ₹5.66 Cr |
| Mar2021 | ₹0.77 Cr |
How is Cash Flow from Financing Activities of KWALITY PHARMACEUTICALS Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-14 Cr | Negative | |
| Mar2024 | ₹-17 Cr | Negative | |
| Mar2023 | ₹0.99 Cr | -82.43 | |
| Mar2022 | ₹5.66 Cr | 637.55 | |
| Mar2021 | ₹0.77 Cr | - | |
Compare Cash Flow from Financing Activities of peers of KWALITY PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KWALITY PHARMACEUTICALS | ₹1,514.9 Cr | -5.9% | 3.2% | 120% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹430,645.0 Cr | 2.9% | 3.6% | 0.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,625.0 Cr | 0.6% | -4.5% | 3.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹145,415.0 Cr | 2.1% | -0.4% | 31.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,664.0 Cr | 2.2% | -0.4% | 6.2% | Stock Analytics | |
| CIPLA | ₹100,480.0 Cr | 0.4% | -6.2% | -19.4% | Stock Analytics | |
KWALITY PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KWALITY PHARMACEUTICALS | -5.9% |
3.2% |
120% |
| SENSEX | -1.9% |
-9.1% |
-0.2% |
You may also like the below Video Courses